While both Ajanta Pharma and Zydus Life inked licensing deals, Emcure Pharma's unit has received an establishment inspection report (EIR) from the US Drug Regulator.While both Ajanta Pharma and Zydus Life inked licensing deals, Emcure Pharma's unit has received an establishment inspection report (EIR) from the US Drug Regulator.
These three Pharma stocks should be on your radar today; Key factors explained
API Publisher